These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10419225)

  • 1. Program quality effects on patient outcomes during methadone maintenance: a study of 17 clinics.
    Magura S; Nwakeze PC; Kang SY; Demsky S
    Subst Use Misuse; 1999 Jul; 34(9):1299-324. PubMed ID: 10419225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone maintenance treatment (MMT) in general practice or in specialized centers: profile of patients in the Swiss Canton of Vaud.
    Pelet A; Doll S; Huissoud T; Resplendino J; Besson J; Favrat B
    Am J Drug Alcohol Abuse; 2007; 33(5):665-74. PubMed ID: 17891659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of benzodiazepine use on methadone maintenance treatment outcomes.
    Brands B; Blake J; Marsh DC; Sproule B; Jeyapalan R; Li S
    J Addict Dis; 2008; 27(3):37-48. PubMed ID: 18956528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal patterns of heroin and cocaine use among methadone patients.
    Magura S; Kang SY; Nwakeze PC; Demsky S
    Subst Use Misuse; 1998 Oct; 33(12):2441-67. PubMed ID: 9781824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different components of opioid-substitution treatment predict outcomes of patients with and without a parent with substance-use problems.
    Trafton JA; Tracy SW; Oliva EM; Humphreys K
    J Stud Alcohol Drugs; 2007 Mar; 68(2):165-72. PubMed ID: 17286334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary evaluation of methadone program in Kraków].
    Kamenczak A; Chrostek Maj J; Kroch S; Groszek B
    Przegl Lek; 2000; 57(10):525-30. PubMed ID: 11199879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring program performance in methadone treatment using in-treatment outcomes: an illustration.
    Phillips CD; Hubbard RL; Dunteman G; Fountain DL; Czechowicz D; Cooper JR
    J Ment Health Adm; 1995; 22(3):214-25. PubMed ID: 10172390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monitoring and evaluation of the Hungarian methadone maintenance programmes].
    Rácz J; Melles K; Márványkövi F; Vadász V
    Psychiatr Hung; 2010; 25(3):202-20. PubMed ID: 20884995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.
    Karow A; Reimer J; Schäfer I; Krausz M; Haasen C; Verthein U
    Drug Alcohol Depend; 2010 Dec; 112(3):209-15. PubMed ID: 20728288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methadone, maintenance program and reduction of drug abuse. An expanding practice].
    Tremblay M
    Perspect Infirm; 2005; 2(3):40-1. PubMed ID: 15686211
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release.
    Gordon MS; Kinlock TW; Schwartz RP; O'Grady KE
    Addiction; 2008 Aug; 103(8):1333-42. PubMed ID: 18855822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment failure and methadone dose in a public methadone maintenance treatment programme in Geneva.
    Mino A; Page D; Dumont P; Broers B
    Drug Alcohol Depend; 1998 May; 50(3):233-9. PubMed ID: 9649977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining and Predicting Opioid and Cocaine Treatment Response.
    Gardner RA; Epstein DH; Preston KL; Phillips KA
    Subst Use Misuse; 2019; 54(13):2134-2143. PubMed ID: 31315479
    [No Abstract]   [Full Text] [Related]  

  • 14. Opiate-dependent patients receiving methadone. How physicians should manage therapy.
    Kahan M; Sutton N
    Can Fam Physician; 1996 Sep; 42():1769-78. PubMed ID: 8828879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term outcomes of drug use by methadone maintenance patients.
    Bovasso G; Cacciola J
    J Behav Health Serv Res; 2003; 30(3):290-303. PubMed ID: 12875097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premature discharge from methadone treatment: patient perspectives.
    Reisinger HS; Schwartz RP; Mitchell SG; Peterson JA; Kelly SM; O'Grady KE; Marrari EA; Brown BS; Agar MH
    J Psychoactive Drugs; 2009 Sep; 41(3):285-96. PubMed ID: 19999682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
    Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
    Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mandatory short-term methadone-to-abstinence program in New York City.
    Winick C
    Mt Sinai J Med; 2001 Jan; 68(1):41-5. PubMed ID: 11135505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.